Tom Parke, Scott Berry, and Kert Viele present the latest in clinical trial simulation. Later this year Tessella and Berry consultants will be releasing version 3 of their Fixed and Adaptive Clinical Trial Simulator (FACTS). Oxford, UK | 20 May 2013. Tessella, the international provider of science powered technology and consulting services and Berry [...]
Join Tom Parke to learn more about using clinical trial simulations and calculations of expected net present value (eNPV) to optimise development decisions and trial designs. Two examples of simulating and optimising drug development plans are presented — 1. DIA Adaptive Program (Oncology sub-stream), looking at the problem of how best to develop two candidate [...]
Tessella’s Tom Parke, Head of Clinical Technologies, will be holding three separate talks at the DIA 23rd Annual Euro Meeting, taking place on March 28-30th, 2011, Geneva, Switzerland. Tom’s topics are: Incorporating biomarker data in clinical trials for developing personalised medicine Commercial Software Solutions for Exploratory Studies Using simulations to communicate the expected consequences of planned statistical analyses To find [...]
Tessella are sponsoring this year’s 2010 Accelrys European User Group Meeting, taking place at the Dolce Sitges Hotel in Barcelona, Spain on October 26-28th 2010. Mark Roberts from Tessella and Ed Ainscow from AstraZeneca will be speaking at the event. The title of their abstract is ‘A Flexible Platform for Processing High-Content Screening Data’ which [...]
Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST) 17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]
The FACTS User Group Meeting will be taking place on July 20th and 21st 2010 at Le Meridien, Cambridge, Massachusetts, USA. For further information about this event, please email info@tessella.com. For information about FACTS and clinical trial solutions, visit www.smarterclinicaltrials.com
Major changes to the way cancer drugs are tested in people could lead to better and cheaper therapies coming to the market more quickly…read more
Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help: • Maximize the impact of your clinical trials on your drug development process. [...]
Yili Pritchett of Abbott was able to show real data from a trial we ran for them between 2007-2009. Read more.
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue [...]
